Publications

Detailed Information

Topical tacrolimus 0.03% for maintenance therapy in steroid-dependent, recurrent phlyctenular keratoconjunctivitis

Cited 5 time in Web of Science Cited 6 time in Scopus
Authors

Yoon, Chang Ho; Kim, Mee Kum; Oh, Joo Youn

Issue Date
2018-01
Publisher
Lippincott Williams & Wilkins Ltd.
Citation
Cornea, Vol.37 No.2, pp.168-171
Abstract
Purpose: To evaluate the efficacy of topical tacrolimus 0.03% as steroid-free maintenance therapy in young patients with severe, recurrent phlyctenular keratoconjunctivitis (PKC). Methods: The medical records of 6 eyes of 5 patients (4 children and 1 young adult) with recurrent, steroid-dependent PKC were reviewed. The patients were treated with combined application of topical steroids and tacrolimus 0.03% in the active phase and maintained on topical tacrolimus alone after remission. Results: The clinical signs, symptoms, and visual acuities resolved in all patients after 25.2 +/- 16.9 days of combined treatment with steroids and tacrolimus. After disease remission, the patients were maintained on topical tacrolimus 0.03% once daily alone for 8.4 +/- 4.7 months, and no recurrence occurred during 10.6 +/- 1.9 months of follow-up. Tacrolimus was successfully discontinued in 2 patients without further recurrence. There were no ocular side effects related to the use of topical tacrolimus. Conclusions: Topical tacrolimus 0.03% was effective in maintaining long-term remission in patients with recurrent, steroid-dependent PKC.
ISSN
0277-3740
URI
https://hdl.handle.net/10371/202849
DOI
https://doi.org/10.1097/ICO.0000000000001440
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area 각막 및 외안부 질환, 백내장

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share